Skip to main content

BioLife Solutions, Inc. (BLFS)

NASDAQ: BLFS · Delayed Price · USD
47.49 1.50 (3.26%)
Sep 17, 2021 4:00 PM EDT - Market closed
Market Cap1.96B
Revenue (ttm)74.06M
Net Income (ttm)3.54M
Shares Out38.07M
EPS (ttm)0.11
PE Ratio416.58
Forward PE2,500.00
Dividendn/a
Ex-Dividend Daten/a
Volume1,119,369
Open46.00
Previous Close45.99
Day's Range45.08 - 47.97
52-Week Range24.56 - 60.67
Beta1.41
AnalystsBuy
Price Target62.14 (+30.8%)
Est. Earnings DateNov 4, 2021

About BLFS

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line ...

IndustryHealth Care Equipment & Supplies
IPO DateNov 22, 1989
CEOMichael Rice
Employees193
Stock ExchangeNASDAQ
Ticker SymbolBLFS
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for BLFS stock is "Buy." The 12-month stock price forecast is 62.14, which is an increase of 30.85% from the latest price.

Price Target
$62.14
(30.85% upside)
Analyst Consensus: Buy

News

BioLife Solutions Announces CFO Retirement

BOTHELL, Wash., Sept. 15, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services...

2 days ago - PRNewsWire

Why Shares in BioLife Solutions Jumped 24.4% in August

The company, which specializes in cold-storage solutions for biotechs, had a hot month.

1 week ago - The Motley Fool

BioLife Solutions Files Form S-3 Registration Statement to Register Shares from Completed Acquisitions

BOTHELL, Wash., Sept. 1, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services...

2 weeks ago - PRNewsWire

BioLife Solutions Closes Acquisition of Sexton Biotechnologies

BOTHELL, Wash., Sept. 1, 2021 /PRNewswire/ --  BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services...

2 weeks ago - PRNewsWire

2 Little-Known Nasdaq Stocks Making Big Moves Wednesday

Don't let these companies fly under your radar.

Other symbols:SAVA
3 weeks ago - The Motley Fool

BioLife Solutions Joins S&P SmallCap 600 Index

BOTHELL, Wash., Aug. 25, 2021 /PRNewswire/ --  BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and service...

3 weeks ago - PRNewsWire

BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Top Estimates

BioLife Solutions, Inc. (BLFS) delivered earnings and revenue surprises of 480.00% and 10.19%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Recap: BioLife Solutions Q2 Earnings

Shares of BioLife Solutions (NASDAQ:BLFS) moved higher by 4.2% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 100.00% over the past year to (...

1 month ago - Benzinga

BioLife Solutions Announces Second Quarter 2021 Financial Results

BOTHELL, Wash., Aug. 12, 2021 /PRNewswire/ --  BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and service...

1 month ago - PRNewsWire

Sexton Biotechnologies to be Acquired by Biolife Solutions

INDIANAPOLIS, Aug. 9, 2021 /PRNewswire/ -- Sexton Biotechnologies, a provider of novel manufacturing solutions for the cell and gene therapy (CGT) industry, today announced that it has entered into a de...

1 month ago - PRNewsWire

BioLife Solutions to Acquire Sexton Biotechnologies to Expand Cell and Gene Therapy Tools Portfolio

BOTHELL, Wash., Aug. 9, 2021 /PRNewswire/ --  BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services...

1 month ago - PRNewsWire

BioLife Solutions to Report Second Quarter 2021 Financial Results and Provide Business Update on August 12, 2021

BOTHELL, Wash., Aug. 5, 2021 /PRNewswire/ --  BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction produc...

1 month ago - PRNewsWire

BioLife Solutions, Inc. (BLFS) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

BioLife Solutions, Inc. (BLFS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

BioLife Solutions Announces Changes to Board of Directors

BOTHELL, Wash., July 14, 2021 /PRNewswire/ --  BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and service...

2 months ago - PRNewsWire

BioLife Solutions Adopts New Brand Identity

BOTHELL, Wash., June 15, 2021 /PRNewswire/ --  BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and service...

3 months ago - PRNewsWire

BioLife Solutions Announces Promotion of Caitlin Rice to Global Vice President, Customer Service

BOTHELL, Wash., May 19, 2021 /PRNewswire/ --  BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services...

3 months ago - PRNewsWire

BioLife Solutions, Inc. (BLFS) Reports Q1 Loss, Tops Revenue Estimates

BioLife Solutions, Inc. (BLFS) delivered earnings and revenue surprises of 40.00% and 8.01%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

BioLife Solutions to Report First Quarter 2021 Financial Results and Provide Business Update on May 13, 2021

BOTHELL, Wash., May 6, 2021 /PRNewswire/ --  BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction product...

4 months ago - PRNewsWire

Earnings Preview: BioLife Solutions, Inc. (BLFS) Q1 Earnings Expected to Decline

BioLife Solutions, Inc. (BLFS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 months ago - Zacks Investment Research

BioLife Solutions Announces Closing of Stirling Ultracold Acquisition and Expanded Partnership with Leading Global Bi...

BOTHELL, Wash., May 3, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction products...

4 months ago - PRNewsWire

BioLife Solutions Launches New High Capacity Controlled Rate Freezer Line with First Shipment to a Leading Cell Thera...

BOTHELL, Wash., April 15, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction produc...

5 months ago - PRNewsWire

HRC or BLFS: Which Is the Better Value Stock Right Now?

HRC vs. BLFS: Which Stock Is the Better Value Option?

Other symbols:HRC
5 months ago - Zacks Investment Research

BioLife Solutions Appoints Two New Independent Board Directors

BOTHELL, Wash., April 6, 2021 /PRNewswire/ --  BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction produ...

5 months ago - PRNewsWire

HRC vs. BLFS: Which Stock Is the Better Value Option?

HRC vs. BLFS: Which Stock Is the Better Value Option?

Other symbols:HRC
5 months ago - Zacks Investment Research

BioLife Solutions, Inc. (BLFS) Reports Q4 Loss, Tops Revenue Estimates

BioLife Solutions, Inc. (BLFS) delivered earnings and revenue surprises of 0.00% and 9.67%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research